Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial

Frederiek F. van Doormaal*, Alexander T. Cohen, Bruce L. Davidson, Herve Decousus, Alexander S. Gallus, Michael Gent, Franco Piovella, Martin H. Prins, Gary E. Raskob, Harry R. Bueller

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Web of Science)
Original languageEnglish
Pages (from-to)86-91
JournalThrombosis and Haemostasis
Volume104
Issue number1
DOIs
Publication statusPublished - Jul 2010

Keywords

  • Anticoagulation
  • cancer
  • idraparinux
  • deep venous thrombosis

Cite this